Revisión

Practical issues with the use of rivaroxaban

C. Suárez-Fernández, V. Roldán, J. Vivancos [REV NEUROL 2013;57:411-421] PMID: 24150953 DOI: https://doi.org/10.33588/rn.5709.2013058

OPEN ACCESS

Volumen 57 | Number 09 | Nº of views of the article 4.672 | Nº of PDF downloads 699 | Article publication date 01/11/2013

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

Rivaroxaban is an oral highly selective direct factor Xa inhibitor. Rivaroxaban is currently approved for the prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery, for the treatment of deep vein thrombosis and pulmonary embolism and long-term secondary prevention of venous thromboembolism, and for stroke and systemic embolism prevention in patients with nonvalvular atrial fibrillation. Rivaroxaban has many advantages over vitamin K antagonists and this may facilitate its use in clinical practice. As a result, it is expected that new oral anticoagulants may change patient management strategies. On the other hand, rivaroxaban has some particularities that are necessary to know. The aim of this manuscript was to review the use of rivaroxaban not only in general population, but also in specific patients groups and clinical situations to achieve an optimal management with this drug in daily clinical practice. KeywordsAnticoagulation Atrial fibrillation Deep vein thrombosis Rivaroxaban Stroke Treatment Venous thromboembolism CategoriesPatología vascular Técnicas exploratorias

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Revisión

Practical issues with the use of rivaroxaban

¡CONVIÉRTASE EN USUARIO PREMIUM DE NEUROLOGIA.COM!

Al hacerse premium, está apoyándonos para que Revista de Neurología siga siendo uno de los referentes de habla hispana en la difusión del conocimiento en neurociencias. ¡Gratuita tanto para autores como para todos los usuarios de la web!